Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 7
1995 3
1996 6
1997 2
1998 2
1999 4
2000 5
2001 1
2002 3
2003 4
2004 5
2005 4
2006 1
2007 2
2008 5
2009 5
2010 5
2011 5
2012 3
2013 4
2014 8
2015 10
2016 11
2017 17
2018 12
2019 12
2020 24
2021 20
2022 24
2023 23
2024 29
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study.
De Placido P, Di Rienzo R, Pietroluongo E, Martinelli C, Tafuro M, Formisano P, D'Esposito V, Poggio FB, Ruelle T, Cardinali B, Di Lauro V, Buono G, Caputo R, Buonaiuto R, Caltavituro A, Rocco P, Porciello G, De Laurentiis M, Del Mastro L, Vernieri C, Veneziani BM, Bianco R, Crispo A, De Angelis C, Arpino G, Giuliano M. De Placido P, et al. Among authors: de laurentiis m. Eur J Cancer. 2025 Apr 4;221:115409. doi: 10.1016/j.ejca.2025.115409. Online ahead of print. Eur J Cancer. 2025. PMID: 40220739 Free article.
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer.
Berton Giachetti PPM, Morganti S, Gandini S, Giudici F, Marra A, Nicolò E, Zattarin E, Corti C, Boldrini L, Verrazzo A, Sposetti C, Razeti MG, Carnevale Schianca A, Scafetta R, Taurelli Salimbeni B, Esposito A, Zagami P, Trapani D, Malagutti B, Caputo R, Vernieri C, Munzone E, Scagnoli S, Botticelli A, Lambertini M, Giuliano M, De Laurentiis M, Viale G, Bianchini G, Curigliano G, De Angelis C, Criscitiello C. Berton Giachetti PPM, et al. Among authors: de laurentiis m. JAMA Netw Open. 2025 Feb 3;8(2):e2461067. doi: 10.1001/jamanetworkopen.2024.61067. JAMA Netw Open. 2025. PMID: 39982725 Free PMC article.
Prognostic implications of risk definitions from the monarchE and NATALEE trials.
Arecco L, Blondeaux E, Bruzzone M, Arpino G, De Angelis C, De Laurentiis M, Caputo R, Fabi A, Sanna V, Gori S, Puglisi F, Boni L, Nardin S, Giannubilo I, Perachino M, Borea R, Agostinetto E, de Azambuja E, Lambertini M, Del Mastro L. Arecco L, et al. Among authors: de laurentiis m. J Natl Cancer Inst. 2025 Feb 5:djaf031. doi: 10.1093/jnci/djaf031. Online ahead of print. J Natl Cancer Inst. 2025. PMID: 39908473
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan.
Fabi A, Rossi A, Caputo R, Pisegna S, Scagnoli S, Pantano F, D'Auria G, Fedele P, Fabbri A, Vernieri C, Palleschi M, Carbognin L, Ferretti G, Di Monte E, Paris I, Pavese F, Garrone O, Franco A, De Laurentiis M, Franceschini G, Scambia G, Giannarelli D, Masetti R, Botticelli A. Fabi A, et al. Among authors: de laurentiis m. NPJ Precis Oncol. 2025 Jan 22;9(1):22. doi: 10.1038/s41698-025-00801-3. NPJ Precis Oncol. 2025. PMID: 39843642 Free PMC article.
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world.
Blondeaux E, Boni L, Chilà G, Dri A, Caputo R, Poggio F, Fabi A, Arpino G, Pravisano F, Geuna E, Delucchi V, Ruelle T, Giannubilo I, De Laurentiis M, Puglisi F, Bighin C, Lambertini M, Montemurro F, Del Mastro L. Blondeaux E, et al. Among authors: de laurentiis m. ESMO Open. 2025 Feb;10(2):104125. doi: 10.1016/j.esmoop.2024.104125. Epub 2025 Jan 21. ESMO Open. 2025. PMID: 39842245 Free PMC article.
Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell Death.
Mazzarotti G, Cuomo M, Ragosta MC, Russo A, D'Angelo M, Medugno A, Napolitano GM, Iannuzzi CA, Forte IM, Camerlingo R, Burk S, Errichiello F, Frusciante L, Forino M, Campitiello MR, De Laurentiis M, Giordano A, Alfano L. Mazzarotti G, et al. Among authors: de laurentiis m. Int J Mol Sci. 2024 Dec 16;25(24):13475. doi: 10.3390/ijms252413475. Int J Mol Sci. 2024. PMID: 39769237 Free PMC article.
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients.
Gravina A, Gargiulo P, De Laurentiis M, Arenare L, De Placido S, Orditura M, Cinieri S, Riccardi F, Ribecco AS, Putzu C, Del Mastro L, Rossi E, Ciardiello F, Di Rella F, Nuzzo F, Pacilio C, Caputo R, Cianniello D, Forestieri V, Giuliano M, Arpino G, Orlando L, Mocerino C, Schettino C, Piccirillo MC, Gallo C, Perrone F. Gravina A, et al. Among authors: de laurentiis m. ESMO Open. 2025 Jan;10(1):104085. doi: 10.1016/j.esmoop.2024.104085. Epub 2025 Jan 3. ESMO Open. 2025. PMID: 39754976 Free PMC article. Clinical Trial.
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer.
Cucciniello L, Blondeaux E, Bighin C, Gasparro S, Russo S, Dri A, Pugliese P, Fontana A, Cortesi E, Ferzi A, Riccardi F, Sini V, Boni L, Fabi A, Montemurro F, De Laurentiis M, Arpino G, Del Mastro L, Gerratana L, Puglisi F. Cucciniello L, et al. Among authors: de laurentiis m. NPJ Breast Cancer. 2024 Dec 18;10(1):105. doi: 10.1038/s41523-024-00713-8. NPJ Breast Cancer. 2024. PMID: 39695115 Free PMC article.
254 results